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CASE REPORTS

1

Numerous medical disorders, including obstructive sleep apnea,
may cause nocturnal diaphoresis. Previous work has associated severe obstructive sleep apnea with nocturnal diaphoresis.
This case report is of import as our patient with severe nocturnal
diaphoresis manifested only mild sleep apnea, and, for years,
his nocturnal diaphoresis was ascribed to other causes, i.e., first
prostate cancer and then follicular B-cell lymphoma. Additionally,
it was the nocturnal diaphoresis and not more common symp-

toms of obstructive sleep apnea, such as snoring, that led to the
definitive diagnosis of his sleep apnea and then to treatment with
a gratifying resolution of his onerous symptom.
keywords: Diaphoresis, sleep apnea
Citation: Vorona RD; Szklo-Coxe M; Fleming M; Ware JC.
Nocturnal diaphoresis secondary to mild obstructive sleep
apnea in a patient with a history of two malignancies. J Clin
Sleep Med 2013;9(7):717-719.

D

iverse medical disorders including malignancies, infections, and endocrine abnormalities have been associated
with nocturnal diaphoresis.1 Nocturnal diaphoresis may occur
in obstructive sleep apnea syndrome (OSAS).2 Nevertheless,
research has been limited and findings mixed.3,4 One study
found night sweats to be associated with snoring and sleepiness but not apnea-hypopnea index (AHI).3 Excessive nocturnal sweating occurred in 34% of patients with severe OSAS
([AHI] = 52).4 Our case is instructive as our patient’s severe
nocturnal diaphoresis occurred with mild OSAS and was not
clearly connected to his two malignancies.

hol and no caffeine. He ceased smoking cigarettes in 1975 and
reported a comfortable bedroom temperature.
Past medical history: Prostate cancer history (treated first
with surgery, then with radiation therapy in 2006 for micrometastatic disease), follicular B-cell lymphoma, radiation cystitis, coronary heart disease, supraventricular and ventricular
dysrhythmias (dronederone previously stopped given concerns
it contributed to diaphoresis), pacemaker implantation, adenomatous colon polyps with dysplasia, pneumonia, previous left
upper extremity thrombophlebitis, gastroesophageal reflux
disease (GERD), Barrett’s esophagus, and distant tonsillectomy history.
Medications (at time of initial sleep center visit) included
clopidogrel, niacin, atorvastatin, aspirin, flecainide, pantoprazole, lubiprostone, glucosamine/chondroitin, and fish oil.
Review of systems demonstrated no recent change in weight,
no history of diabetes mellitus or thyroid disease, and some difficulties with memory and concentration.
Exam demonstrated a tall, slender male with normal respiratory rate and pulse. Upper airway exam revealed no frank anterior septal deviation. He had a large tongue, borderline class III
malocclusion, Mallampati IV, retrognathia, and 15-inch neck
circumference. Neck exam revealed normal thyroid, and no
cervical, supraclavicular, or axillary adenopathy. Cardiopulmonary exam: normal lung sounds and heart tones, and a pacemaker. There was no cyanosis, clubbing, or edema.
The patient’s diagnostic and continuous positive airway pressure (CPAP) polysomnographic data are presented in Table 1.
By numeric indices, the patient’s diagnostic study manifested
mild apnea that was more pronounced in stage R sleep. Pre and
post blood pressures were normal at 109/67 and 104/64, respectively. Esophageal pressure monitoring and ambulatory blood
pressure monitoring were not done as part of the patient’s clinical evaluation.

REPORT OF CASE
A 67-year-old male first manifested diaphoresis in 2002 following a radical prostatectomy for T2N0MX prostate cancer.
His clinicians reassured him that diaphoresis, common after
surgery, should resolve.
It worsened; the patient often soaked through clothing and
slept on a towel. Endocrine evaluation was negative. A negative QFT Gold Test for tuberculosis, negative HIV test, normal
erythrocyte sedimentation rate test (1), and normal testosterone
level (444) were obtained in 2010. However, follicular B-cell
lymphoma was diagnosed (1/2011) and thought the likely cause
of profuse, almost nightly sweats. The Rituximab treatment for
lymphoma (3/2011) did not improve his diaphoresis. The patient’s oncologist recommended sleep medicine consultation.
The patient presented 6/2011 to sleep medicine with a chief
complaint of “severe night sweats that have gotten progressively worse over the last 12 months.” Sweating was most apparent
02:30 until 04:00. His registered nurse wife noted infrequent
snoring and pauses in respiration. He denied restless sleep. Epworth Sleepiness Scale score was normal (5), though he felt
tired upon arising after 7-8 hours in bed. He used minimal alco717
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Table 1—Summary of polysomnographic data
Study Date
06/09/11
06/22/11

Max.
CPAP
0
9b

AHIa
7
1

Supine
REM AHI
AHI
27
7
0
1

Low O2
%
89
94

Length
(s)
21
26

Max
Length
(s)
52
29

Arousal
Index
8
14

Total
Sleep
Sleep Efficiency
(min)
%
381
93
326
78

Min
REM
53
29

PLMS/h
0
0

BMI
(kg/m2)
22.7
23.1

a
Hypopneas defined as: ≥ 30% decline in tidal volume for ≥ 10 seconds associated with ≥ 4% oxygen desaturation. bThe AHI on the CPAP titration study of
6/22/11 is averaged over all CPAP pressures.

The CPAP titration study revealed control of the patient’s
apnea and improved oxygen nadir. Blood pressures pre and post
study, respectively, were again normal at 101/63 and 99/57. In
neither study was there evidence for other sleep pathology such
as periodic limb movements of sleep.
The patient began CPAP at 9 cwp. At 1-month follow-up, he
noted near-disappearance of nocturnal diaphoresis. Diaphoresis
had taken a few days after CPAP initiation to dissipate. Medications including niacin remained unchanged. A CPAP download revealed that during the first month (7/12/11-8/10/11), the
patient used the machine 5 h 45 min per night, with 87% of
the time ≥ 4 h and with an AHI of 2.9 on 9 cwp. His daily records for the preceding month indicated no night sweats save
for “moist” neck area and armpits on 3 nights.
Endocrinology work up (8/2011), requested by the patient’s
oncologist, revealed normal renal, hepatic, and glucose levels.
The overall thyroid panel suggested “borderline low” thyroid
function, yet TSH was normal (2.94).
His last visit (8/2012) revealed continued control of his diaphoresis with CPAP therapy. He noted some diaphoresis and
snoring with CPAP interface slippage.
A CPAP download from 7/8/11-8/1/12 revealed that the patient used his CPAP machine an average of 5 h 8 min per night,
with 77% of the time ≥ 4 h and with an AHI of 1.6 on 9 cwp.
At one and a half years post CPAP initiation, on phone communication, the patient believed his diaphoresis was still dramatically improved. The patient stated that if he stopped CPAP
that the first night he would sweat only modestly. With CPAP
discontinuation for a few days, he noted that increasingly severe diaphoresis ensued.

for RERAs. For example, the patient’s breathing was usually inphase, and the intercostal electromyogram signals were almost
exclusively quiet. We did not see subtle out-of-phase breathing
terminating in arousals. The normal arousal index also argued
against our missing subtle upper airway events.
Sleep stages have been associated with different predispositions to diaphoresis. For that reason, we looked for changes in
stage N3 sleep (the stage with greatest diaphoresis) and stage
R sleep (the stage ostensibly with the least) that might have
explained his diaphoresis and response to therapy. We found no
explanation in our review of the sleep architecture (please see
minutes of stage R for each study in Table 1. The patient had no
stage N3 on either study).
We did not analyze heart rate variability (HRV), a measure
of autonomic function. With only one night in each condition,
selecting samples for analysis while controlling for proximity
of apnea events, proximity of arousals, sleep stage, and time of
night was beyond our capability.
The severe night sweats in this patient with mild OSAS
were noteworthy. Few studies3,4 have investigated diaphoresis in OSAS. Electrodermal activity has also been utilized to
probe this relationship in patients with severe apnea (AHI =
45.3).5 These findings, however, may not be generalizable to
our patient, who had much milder apnea. Future studies aimed
at assessing the prevalence of diaphoresis in mild OSAS and
clarifying its pathophysiological basis may be warranted. Perhaps this severe diaphoresis reflects individual variability, just
as some patients with mild OSAS by numeric indices may have
severe sleepiness. The patient’s sympathetic nervous system
may have been more sensitive to the impact of OSAS, and the
sweating may have reflected heightened autonomic activity.
The association of autonomic dysfunction with mild OSAS was
previously reported in 2004,6 and, in 2008, systolic non-dipping
of blood pressure was reported to be associated with sleep apnea, even mild apnea. 7
Finally, this patient had a history of GERD. GERD has itself
been reported to cause nocturnal sweats,8 to be comorbid with
OSAS, and improved by CPAP.9 While the improvement of diaphoresis by CPAP may have been due to GERD reduction, the
patient presented to the sleep center with diaphoresis notwithstanding use of a proton pump inhibitor. Thus, CPAP treatment
of OSAS was likely primarily responsible for the gratifying response described herein.

DISCUSSION
Firstly, this report illustrates the importance of not excluding OSAS from the differential diagnosis of nocturnal diaphoresis, despite other more obvious potential etiologies. Secondly,
this case indicates that even mild OSAS may result in severe
diaphoresis, extending findings regarding its presence in severe
OSAS. 4 Thirdly, CPAP both treated mild OSAS and resolved
the troubling night sweats. This case emphasizes the onerous
nature of diaphoresis in OSAS, even when unaccompanied by
more typical symptoms, such as prolific snoring and sleepiness.
In this case, severe nocturnal diaphoresis was our primary clue
to the presence of OSAS.
It is possible that the AHI underestimated the patient’s degree of respiratory instability and that the patient may have had
concomitant respiratory event related arousals (RERAs). However, a careful review of the raw data did not reveal evidence
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